A multinuclear MR study of Gd-EOB-DTPA: Comprehensive preclinical characterization of an organ specific MRI contrast agent

Magnetic Resonance in Medicine

Volumn 38, Issue 4, 1997, Pages 604-614

  Vander Elst, Luce ^a   Maton, Frédéric ^a   Laurent, Sophie ^a   Seghi, Frédéric ^a   Chapelle, Florence ^a   Muller, Robert N ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

Gd EOB DTPA; Hepatobiliary MRI contrast media; Multinuclear relaxometry; Perfused liver

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOMOLECULES; CONTRAST MEDIA; DISSOCIATION; GADOLINIUM; IONS; METABOLITES; PHOSPHATES; PHOSPHORYLATION; PROTEINS; THERMODYNAMIC STABILITY;

GD-EOB-DTPA; INTRACELLULAR METABOLITES; MRI CONTRASTS; NON-COVALENT INTERACTION; NUCLEAR MAGNETIC RELAXATION DISPERSION; RELAXOMETRY; ROTATIONAL CORRELATION TIME; TRANSVERSE RELAXATION RATE;

NUCLEAR MAGNETIC RESONANCE;

ADENOSINE TRIPHOSPHATE; CONTRAST MEDIUM; CREATINE PHOSPHATE; GADOLINIUM 3,6,9 TRIAZA 3,6,9 TRIS(CARBOXYMETHYL) 4 (4 ETHOXYBENZYL)UNDECANDICARBOXYLIC ACID; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE DERIVATIVE; HUMAN SERUM ALBUMIN; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG UPTAKE; EQUILIBRIUM DIALYSIS; LIVER; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 0030986481     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380415     Document Type: Article

References (33)

1. A. Mühler, J. Heinzelmann, H.-J. Weinmann, Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Invest. Radiol. 29, 213-216 (1994).
2. G. Schuhmann-Giampieri, H. Schmitt-Willich, W.-R. Press, C. Negishi, H.-J. Weinmann, U. Speck, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183, 59-64 (1992).
3. H.-J. Weinmann, G. Schuhmann-Giampieri, H. Schmitt-Willich, H. Vogler, T. Frenzel, H. Gries. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn. Reson. Med. 22, 233-237 (1991).
4. B. Hamm, T. Staks, A. Mühler, M. Bollow, M. Taupitz, T. Frenzel, K.-J. Wolf, H.-J. Weinmann, L. Lange, Phase 1 clinical evaluation of Gd-EOB-DTPA as a hopatobiliary MR contrast agent: safety, pharmacokinetics and MR imaging. Radiology 195, 785-792 (1995).
5. P. Reimer, E. J. Rummeny, K. Shamsi, T. Balzer, H. E. Daldrup, B. Tombach, T. Hesse, T. Berns, P. E. Peters, Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199, 177-183 (1996).
6. W. D. Wheeler, J. I. Legg, Assignment of the deuteron NMR spectra of chromium(III) complexes with EDTA and related ligands. Inorg. Chem. 24, 1292-1297 (1985).
7. F. Desmoulin, P. Canioni, C. Crotte, A. Gérolami, P. J. Cozzone, Hepatic metabolism during acute ethanol administration: a phosphorus-31 nuclear magnetic resonance study on the perfused rat liver under normoxic and hypoxic conditions. Hepatology 7, 315-323 (1987).
8. J.-M. Colet, Y. Van Haverbeke, R. N. Muller, Evidence for attachment of magnetic starch microsphores to Kupffer cells receptors in excised and perfused rat liver. Invest. Radiol. 29, S223-S225 (1994).
9. R. N. Muller, D. Declercq, P. Vallet, F. Giberto, B. Daminet, H. W. Fischer, F. Maton, Y. Van Haverbeke, Implementation and operation of an integrated and comprehensive relaxometric data bank, in "Proc., ESMRMB. 7th Annual Congress, Strasbourg, 1990," p. 394.
10. P. Vallet, "Relaxivity of Nitroxide Stable Free Radicals: Evaluation by Field Cycling Method and Optimisation," PhD Thesis, University of Mons-Hainaut, Belgium, 1992.
11. S. H. Koenig, R. D. Brown, III, in "NMR Spectroscopy of Cells and Organisms," (R.K. Gupta, Ed.), vol. II. pp. 75-114, CRC Press, Boca Raton, FL, 1987.
12. F. Uggeri, S. Aime, P. L. Anelli, M. Botta, M. Brocchetta, C. de Haën, G. Ermondi, M. Grandi, P. Paoli, Novel contrast agents for magnetic: resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln(III) complexes (Ln = Gd, La. Ln): x-ray structure of disodium (TPS- 9-145337286-C-S)-[4-carboxy-5,8,11- tris(carboxymethyl)-1-phenyl -2-oxa-5,8,11-triazatridocan-13-oato(5-)]gadolinate(2-) in a mixture with its enantiomer. Inorg. Chem. 34, 633-642 (1995).
13. I. Solomon, Relaxation processes in a system of two spins. Physiol. Rev. 99, 559-565 (1955).
14. N. Bloembergen, Proton relaxation times in paramagnetic solutions. J. Chem. Phys. 27, 572-573 (1957).
15. J. H. Freed. Dynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids. II. Finite jumps and independent T, processes. J. Chem. Phys. 68, 4034-4037 (1978).
16. M. C. Alpoim, A. M. Urbano, C. F. G.C. Geraldes, J. A. Peters, Determination of the number of inner-sphere water molecules in lanthanide(III) polyaminocarboxylate complexes. J. Chem. Soc. Dalton Trans. 463-467 (1992).
17. 2- and [Gd(DOTA)H2O] related to NMK imaging, Inorg. Chem. 32, 3844-3850 (1993).
18. 17O NMR study. J. Phys. Chem. 98, 53-59 (1994).
19. H. H. Mantsch, H. Saito, I. C. P. Smith, Deuterium magnetic resonance, applications in chemistry, physics and biology. Prog. Nucl. Magn. Reson. Spectrosc. 11, 211-272 (1977).
20. Y. Van Haverbeke, R. N. Muller, L. Vander Elst, pH-induced motional and conformational changes of amino acids: a reexamination by deuterium longitudinal nuclear relaxation. J. Phys. Chem. 88, 4978-4980 (1984).
21. W. Derbyshire, T. C. Gorvin, D. Warner, A deuteron magnetic resonance study of a single crystal of deuterated malonic acid. Mol. Phys. 17, 401-407 (1969).
22. 3+ in aqueous glycerol and sucrose solutions. J. Phys. Chem. 99, 5612-5615 (1995).
23. H. R. Pruppacher, Self-diffusion coefficient of supercooled water. J. Chem. Phys. 56, 101-107 (1972).
24. 3+ ions as MRI contrast agents. Magn. Reson. Med. 9, 94-104 (1989).
25. 1 NMRD profiles of gadolinium(III) complexes of monoamide derivatives of DOTA-like ligands: x-ray structure of the 10-[2-[[2-hydroxy-1-(hydroxymethyl) ethyl]amino]-1 -[(phenylmethoxy)methyl] -2 -oxo-ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacotic acid-gadoliniuni(III) complex. Inorg. Chem. 31, 2422-2428 (1992).
26. L. Vander Elst, Y. Van Y. Haverbeke, J.-F. Goudemant, R. N. Muller, Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry. Magn. Reson. Med. 31, 437-444 (1994).
27. R. Kiraly, L. Burai, L Sarka, T. Vig, E. Brücher, Lanthanide complexes of some new DTPA derivatives; equilibrium and kinetic properties, in "Proc., COST D1 European Workshop on MRI Guntrast Agents, 2nd Meeting, The Hague, 1996." p. 21.
28. 1 of solvent water protons. Magn. Reson. Med. 4, 93-111 (1987).
29. I. Bertini, O. Galas, G. Luchinat, G. Parigi, A computer program for the calculation of paramagnetic enhancements of nucluar-relaxation rates in slowly rotating systems. J. Magn. Reson. Ser. A 113, 151-158 (1995)
30. D. C. Carter, J. X. Ho, Structure of serum albumin. Adv. Protein Chem. 45, 153-203 (1994).
31. X. M. Ho, D. C. Carter, Atomic structure and chemistry of human serum albumin, Nature 358, 209-215 (1992).
32. S. Aime, M. Botta, M. Fasano, S. Geninatti Crich, E. Terreno, GH(III) complexes as contrast agents for magnetic resonance imaging: a proton relaxation enhancement study of the interaction with human serum albumin, J. Biol. Inorg. Chem. 1, 312-319 (1998).
33. J. M. Colet, "Study of the Mechanisms of Hepatic Internalisation of Molecular Systems and Nanoparticules, MRI Contrast Agents," PhD thesis, University of Mons-Hainaut, Belgium, 1995.